Simplifying Presbyopia Correction with AcrySof IQ Vivity®† – The first of its kind wavefront shaping IOL (Access to recording here)

17 NOVEMBER 2021

Dr Armand Borovik (Sydney, NSW), Dr Uday Bhatt (Melbourne, Vic) & Dr Richard Smith (Sydney, NSW) discussed and shared their insights on the AcrySof IQ Vivity® IOL. The one-hour webinar discussed the clinical data and results with Vivity, as well as the patient perspective on presbyopia correction and how Vivity can expand the presbyopia correction opportunity. Typically AUSCRS-style, there were some great discussions with questions from the online audience.

If you were unable to make our sixth Conversation Hour, you are able to view it by registering here.  Registration is free. 

Once registered, you will receive a direct link to the recorded presentation.

Chair: Dr Aanchal Gupta (Adelaide, SA)

†Based on intermediate and functional near visual acuity, and spectacle independence with a monofocal visual disturbance profile.

This Conversation Hour was proudly sponsored by:

 

References

  1. AcrySof® IQ Vivity® Extended Vision IOL Directions for Use.
  2. Alcon Data on File, US Patent 9968440 B2, May 15, 2018.
  3. Alcon Data on File, TDOC-0055575. 09 Apr 2019.
  4. Alcon Data on File. TDOC-0055576. 23-Jul-2019.
  5. Alcon Data on File, TDOC-0056718. 18-Jun-2019.
  6. Ligabue E, et al. ACRYSOF IQ VIVITY: Natural vision at a range of distances provided by a novel optical technology. Cataract & Refractive Surgery Today. April 2020 //
  7. Alcon Data on file. A02062-REP-043696, Optical Evaluations of Alcon Vivity®, Symfony, Zeiss AT LARA* AT LISA IOLs. Feb 2020.
  8. Lawless M. Insight news. "An IOL to change the cataract surgery paradigm?" available at "https://www.insightnews.com.au/an-iol-to-change-the-cataract-surgery-paradigm/". Accessed Date 17.07.2020.
  9. Ike K. Ahmed, et al. The Vivity Extended Depth of Focus IOL: Our Clinical Experience. Cataract & Refractive Surgery Today. February 2021.
20-April.jpg

Refractive targeting with EDOF IOL’s – how to get the best clinical outcomes for your patient using TECNIS® Eyhance™, TECNIS® Symfony™ and TECNIS® Synergy™ IOL’s

20 APRIL 2021

Dr Cathryn Edrich (Queensland) and Dr David de la Hunty (Western Australia) discussed refractive targeting of three different IOL technologies, and how they get the best clinical outcomes for their patients.

And again, typically AUSCRS-style, there were some great discussions with questions from the online audience.

If you were unable to make our fifth Conversation Hour, you are able to view it by registering here.  Registration is free. 

Once registered, you will receive a direct link to the recorded presentation.

Chair: Dr. Jay Yohendran (Australia)

This Conversation Hour was proudly sponsored by:

J&J+Logo.jpg
 
Conversation Hour 5 20-April-2021.jpg
Conversation Hour 5 20-April-2021-Presenters.jpg
Conversation Hour calendar 9 Feb 2021.jpg

Phaco Philosophy: Finding the Right Path for Predictability & Control

9 FEBRUARY 2021

Professor Graham Barrett (Australia) and Dr Paul Singh (USA), discussed fluidics and how it impacts every aspect of phaco, including technique, pump type, energy modulation & surgeon control.

They also presented complex cases and shared their experiences on maximising chamber stability using a proactive approach with vacuum based systems.

Typically AUSCRS-style, there were some great discussions with questions from the online audience.

If you were unable to make our fourth Conversation Hour, you are able to view it by registering here.  Registration is free. 

Once registered, you will receive a direct link to the recorded presentation.

Chair: Professor Graham Barrett (Australia)

This Conversation Hour was proudly sponsored by:

Bausch Lomb.jpg
 
Conversation Hour 9 Feb 2021.jpg
Conversation Hour 9 Feb 2021 Presenters.jpg
10-November.jpg

Importance of good IOL design and surgeon experience with TECNIS® Eyhance™ and TECNIS® Synergy™ IOLs.

10 NOVEMBER 2020

Dr. Rob Paul, (Perth, WA) and Dr. Dean Corbett, (Auckland, NZ) discussed their personal experiences using these IOL’s and the outcomes they have achieved.

This webinar, chaired by Dr Dan Black, discussed the importance of good IOL design, especially with the development of new IOL technologies and discussed technology behind TECNIS® Eyhance™ and TECNIS® Synergy™ IOLs and how this relates to better patient outcomes. As typically AUSCRS, there were a lot of ‘conversations’ during this session.

If you were unable to make our third Conversation Hour, you are able to view it by registering here.  Registration is free. 

Once registered, you will receive a direct link to the recorded presentation.

Chair: Dr Dan Black, AUSCRS Committee Member

This Conversation Hour is proudly sponsored by:

J&J Logo.jpg
 
Conversation Hour 10-Nov 2020 v3.jpg
Conversation Hour 10-Nov-2020 3 Presenters.jpg
20-October.jpg

Move Presbyopia Correction Forward with AcrySof® IQ Vivity®, First-of-its kind X-WAVETM technology IOL with monofocal simplicity.1-7

20 OCTOBER 2020

Professor Gerard Sutton (Sydney, NSW), Dr.  Armand Borovik (Sydney, NSW) and Dr. Tess Huyhn (Sydney, NSW) discussed and shared their insights on the AcrySof® IQ Vivity® This webinar discussed some of the technology behind AcrySof® IQ Vivity® and how this translates to its performance in the real world. The panellists covered the use of Vivity® in patients who have existing ocular pathologies, as well as post refractive patients and refractive targeting. Chair: Dr Abi Tenen, AUSCRS Committee Member

If you were unable to make our second Conversation Hour, you are able to view it by registering here.  Registration is free. 

Once registered, you will receive a direct link to the recorded presentation.

Hosted by:

Alcon.jpg
 

1. AcrySof® IQ Vivity®  Extended Vision IOL Directions for Use. 2. Alcon Data on File, US Patent 9968440 B2, May 15, 2018. 3. Alcon Data on File, TDOC-0055575. 09 Apr 2019. 4. Alcon Data on File, TDOC-0056718. 18-Jun-2019. 5. Ligabue E, et al. ACRYSOF IQ VIVITY: Natural vision at a range of distances provided by a novel optical technology. Cataract & Refractive Surgery Today. April 2020 //. 6. Alcon Data on file. A02062-REP-043696, Optical Evaluations of Alcon Vivity®, Symfony*, and Zeiss* AT LARA* IOLs. 7. Lawless M. Insight news. "An IOL to change the cataract surgery paradigm?" available at "https://www.insightnews.com.au/an-iol-to-change-the-cataract-surgery-paradigm/". Accessed Date 17.07.2020. © 2020 Alcon Inc, Alcon Laboratories (Australia) Pty Ltd, ABN 88 00 740 830. Ph: 1800 224 153. New Zealand NZBN 9429047030480 Ph: 0800 809 189 ANZ-VIV-2000051.

Conversation Hour 20 Oct.jpg
Conversation Hour 20 Oct Presenters.jpg
8-September.jpg

Trifocal Technology and the Patient Journey

08 SEPTEMBER 2020

Dr Furness discussed and shared his insights on patient selection, maximising visual outcomes and post op management - The Good, The Bad and The Unexpected!

Presenter: Graham Furness

Chair: David Kent

Sponsored by:

Bausch Lomb.jpg
 

If you were unable to make our first Conversation Hour, you are able to view it by registering here.  Registration is free. 

Once registered, you will receive a direct link to the recorded presentation.

Conversation Hour 8 Sept.jpg
video 2.png